Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer
Authors
Keywords
-
Journal
EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 240, Issue 7, Pages 846-853
Publisher
SAGE Publications
Online
2015-01-09
DOI
10.1177/1535370214565075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interactome Analysis Reveals that C1QBP (complement component 1, q subcomponent binding protein) Is Associated with Cancer Cell Chemotaxis and Metastasis
- (2013) Xiaofang Zhang et al. MOLECULAR & CELLULAR PROTEOMICS
- Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32
- (2013) Lilach Agemy et al. MOLECULAR THERAPY
- Significance of hyaluronan binding protein (HABP1/P32/gC1qR) expression in advanced serous ovarian cancer patients
- (2012) Ge Yu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?
- (2012) Andrea Gombos et al. INVESTIGATIONAL NEW DRUGS
- Overexpression of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) in HepG2 Cells Leads to Increased Hyaluronan Synthesis and Cell Proliferation by Up-regulation of Cyclin D1 in AKT-dependent Pathway
- (2012) Rachna Kaul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- gC1qR Expression in Normal and Pathologic Human Tissues
- (2012) Francine R. Dembitzer et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- High proliferation is associated with inferior outcome in male breast cancer patients
- (2012) Cecilia Nilsson et al. MODERN PATHOLOGY
- Interaction of Proliferation Cell Nuclear Antigen (PCNA) with c-Abl in Cell Proliferation and Response to DNA Damages in Breast Cancer
- (2012) Huajun Zhao et al. PLoS One
- Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
- (2011) Elisabeth Luporsi et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death
- (2011) Allison M. McGee et al. CELL CYCLE
- Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin αvβ3 interaction
- (2011) Mansi Prakash et al. CELLULAR SIGNALLING
- Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer Metastasis
- (2011) Ki-Bum Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy
- (2010) Rie Amamoto et al. CANCER SCIENCE
- Current and emerging biomarkers in breast cancer: prognosis and prediction
- (2010) Marion T Weigel et al. ENDOCRINE-RELATED CANCER
- The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies
- (2010) David Sánchez-Martín et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinicopathological significance of calreticulin in breast invasive ductal carcinoma
- (2010) Zin-Mar Lwin et al. MODERN PATHOLOGY
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation
- (2010) V. Fogal et al. MOLECULAR AND CELLULAR BIOLOGY
- Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer
- (2009) C. Ahlin et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
- (2009) R. Agarwal et al. CLINICAL CANCER RESEARCH
- Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer
- (2009) Yan-Bo Chen et al. JOURNAL OF SURGICAL ONCOLOGY
- Co-Targeting Insulin-Like Growth Factor I Receptor and HER2: Dramatic Effects of HER2 Inhibitors on Nonoverexpressing Breast Cancer
- (2008) A. K. Chakraborty et al. CANCER RESEARCH
- Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma
- (2008) V. Fogal et al. CANCER RESEARCH
- HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924
- (2008) P. Haluska et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now